How to Make Money in a Biotech Industry

X-Lixxis is a biotech company that went public in 2007. The stock has gone up and down over the years, but it's still trading at about 20 per cent above its IPO price. After 14 years as CEO of X-lixxis, he was asked to step down by BioGen this year. "I became convinced that the board actually did not have an agenda," Zuckerman says.